The BRIGHT study, a randomized trial, found that insulin‐naïve type 2 diabetes patients achieved similar within‐day plasma glucose variability with both Deg‐100 and Gla‐300, but a higher rate of nocturnal hypoglycemia episodes was observed during the titration period with Deg‐100.24 This evidence concerns the gene INS and Hypoglycemia.